It is well known that AMACR is a positive marker in about 70% of papillary renal cell carcinomas, 71% of colorectal adenocarcinoma, and 77% of hepatocellular carcinomas (17, 22, 23). Here, AMACR is linked to colorectal adenocarcinoma.